Alexandra Croockewit
About
Alexandra Croockewit is a scholar working on Hematology, Molecular Biology and Oncology.
According to data from OpenAlex, Alexandra Croockewit has authored 20 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Alexandra Croockewit's work include Multiple Myeloma Research and Treatments (8 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Acute Myeloid Leukemia Research (3 papers). Alexandra Croockewit is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Acute Myeloid Leukemia Research (3 papers). Alexandra Croockewit collaborates with scholars based in Netherlands, United States and Belgium. Alexandra Croockewit's co-authors include Bronno van der Holt, Edo Vellenga, Marinus H. J. van Oers, Erik H.J.G. Aarntzen, Roel Mus, I. Jolanda M. de Vries, Michelle M. van Rossum, Gerty Schreibelt, Carl G. Figdor and P. W. Wijermans and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.
In The Last Decade
Alexandra Croockewit
20 papers receiving 773 citations
Peers
Alexandra Croockewit
Keren Osman United States
Sumithira Vasu United States
JA Lust United States
James D. Cavenagh United Kingdom
Danielle Pineau France
Shebli Atrash United States
Josefina Galende Spain
R E Gress United States
Abdul Hamid Bazarbachi United States
Annette M. May Germany
Citations per year, relative to Alexandra Croockewit Alexandra Croockewit (= 1×)
peers
Keren Osman
Countries citing papers authored by Alexandra Croockewit
Since
Specialization
Citations
This map shows the geographic impact of Alexandra Croockewit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Croockewit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Croockewit more than expected).
Fields of papers citing papers by Alexandra Croockewit
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Alexandra Croockewit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Croockewit. The network helps show where Alexandra Croockewit may publish in the future.
Co-authorship network of co-authors of Alexandra Croockewit
This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Croockewit. A scholar is included among the top collaborators of Alexandra Croockewit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Croockewit. Alexandra Croockewit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Plattel, Wouter J., Elizabeth de Kort, Alexandra Croockewit, et al.. (2024). Long-Term Follow-up from the Phase 2 ICON Study of Iberdomide Combined with Low-Dose Cyclophosphamide and Dexamethasone in Relapsed/Refractory Multiple Myeloma (IberCd). Blood. 144(Supplement 1). 3371–3371.
2.
Westdorp, Harm, Jeroen H. A. Creemers, Inge M. van Oort, et al.. (2019). Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer. Journal for ImmunoTherapy of Cancer. 7(1). 302–302.
3.
Verkleij, Christie P.M., Monique C. Minnema, Okke de Weerdt, et al.. (2019). Efficacy and Safety of Nivolumab Combined with Daratumumab with or without Low-Dose Cyclophosphamide in Relapsed/Refractory Multiple Myeloma; Interim Analysis of the Phase 2 Nivo-Dara Study. Blood. 134(Supplement_1). 1879–1879.
4.
Peeters, Hilde, Monique C. Minnema, Tri Q. Nguyen, et al.. (2019). Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options.. PubMed. 77(7). 243–254.
5.
Hazenberg, Bouke P. C., Alexandra Croockewit, Bronno van der Holt, et al.. (2015). Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology. Haematologica. 100(5). 677–682.
6.
Bilgin, Yavuz M., Otto Visser, Erik A.M. Beckers, et al.. (2014). Evaluation of D utch guideline for just‐in‐time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte–colony‐stimulating factor. Transfusion. 55(5). 1021–1027.
7.
Bilgin, Yavuz M., et al.. (2013). Use of Plerixafor in patients that show failure of peripheral blood stem cell mobilization with G-CSF. Experience of three Dutch centers. Transfusion and Apheresis Science. 48(2). 191–191.
8.
Minnema, Monique C., Bouke P. C. Hazenberg, Alexandra Croockewit, et al.. (2013). De behandeling van AL-amyloïdose in Nederland anno 2013: : Adviezen van de HOVON-werkgroep Multipel Myeloom. Data Archiving and Networked Services (DANS). 10(5). 165–179.
9.
Aarntzen, Erik H.J.G., I. Jolanda M. de Vries, W. Joost Lesterhuis, et al.. (2012). Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell–Based Vaccination. Cancer Research. 73(1). 19–29.
10.
Aarntzen, Erik H.J.G., Gerty Schreibelt, Kalijn F. Bol, et al.. (2012). Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients. Clinical Cancer Research. 18(19). 5460–5470.
11.
Holt, Bronno van der, Christine M. Segeren, Edo Vellenga, et al.. (2007). Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial. Haematologica. 92(7). 928–935.
12.
Kappers‐Klunne, M. C., P. W. Wijermans, Rob Fijnheer, et al.. (2005). Splenectomy for the treatment of thrombotic thrombocytopenic purpura. British Journal of Haematology. 130(5). 768–776.
13.
Segeren, Christine M., Pieter Sonneveld, Bronno van der Holt, et al.. (2003). Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study. Blood. 101(6). 2144–2151.
14.
Vellenga, Edo, Michel van Agthoven, Alexandra Croockewit, et al.. (2001). Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study. British Journal of Haematology. 114(2). 319–326.
15.
Segeren, Christine M., Pieter Sonneveld, Bronno van der Holt, et al.. (1999). Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first‐line treatment in untreated multiple myeloma. British Journal of Haematology. 105(1). 127–130.
16.
Croockewit, Alexandra, Miguel H. Bronchud, Matti Aapro, et al.. (1997). A European perspective on haematopoietic growth factors in haemato-oncology: Report of an expert meeting of the EORTC. European Journal of Cancer. 33(11). 1732–1746.
17.
Croockewit, Alexandra, et al.. (1996). CD34 selections from myeloma peripheral blood cell autografts contain residual tumour cells due to impurity, not to CD34+ myeloma cells. British Journal of Haematology. 93(3). 613–622.
18.
Croockewit, Alexandra, Peter P. Koopmans, & B.E. de Pauw. (1996). Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy?. Clinical Pharmacology & Therapeutics. 59(1). 1–6.
19.
Croockewit, Alexandra, et al.. (1995). Selection of CD34-positive cells using immunomagnetic beads results in more than 15 log reduction of malignant cells in myeloma PBC autografts. 23(8). 804.
20.
Croockewit, Alexandra, Reinier Raymakers, Carel Trilsbeek, et al.. (1993). Peripheral Blood Cell Harvests Yield Primitive Multilineage Progenitor Cells in the CD34+/33- Fraction. The International Journal of Artificial Organs. 16(5_suppl). 83–88.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Keren Osman Breakdown of academic impact, for papers by Sumithira Vasu Breakdown of academic impact, for papers by JA Lust Breakdown of academic impact, for papers by James D. Cavenagh Breakdown of academic impact, for papers by Danielle Pineau Breakdown of academic impact, for papers by Shebli Atrash Breakdown of academic impact, for papers by Josefina Galende Breakdown of academic impact, for papers by R E Gress Breakdown of academic impact, for papers by Abdul Hamid Bazarbachi Breakdown of academic impact, for papers by Annette M. May